四川产泽泻中三萜成分的研究

从四川产泽泻中分离出七个泽泻醇类成分,其中24－乙酰泽泻醇F为新确定的立体构型,其它已知成分为泽泻醇F、23－乙酰泽泻醇B、16－羟基－23－乙酰泽泻醇B、13β,17β－环氧泽泻醇B、23－乙酰泽泻醇C、泽泻醇C。     

氮磷钾肥对地道药材建泽泻生长与品质的影响

通过田间正交试验并结合室内HPLC分析,研究了氮、磷和钾素营养对建泽泻〔Alisma orientale(Sam.)Juzepcz.〕生长和品质的影响。结果表明,施用基肥对建泽泻生长前期的叶片数、株高、叶宽和叶长等农艺性状的影响均大于不施基肥处理;氮、磷和钾施用量对建泽泻产量均无显著影响,当施肥量为纯N 225.0 kg.hm-2、P2O5187.5 kg.hm-2和K2O 225.0 kg.hm-2,总施肥量为637.5 kg.hm-2时,产量最高;氮、磷和钾施用量对建泽泻块茎的粒重均无显著影响;磷的施用量对建泽泻指标性成分23-乙酰泽泻醇B含量有显著影响,而氮和钾均没有显著影响,且影响作用从高至低次序依次为P2O5、N、K2O。     

泽泻中二个三萜新成分的研究Ⅱ

继前文鉴定的七个泽泻醇类成分后 ,又从泽泻中分离、鉴定出六个三萜成分 ,其中 11 乙酰 2 5 脱水泽泻醇A(2 5 anhydroalisolA 11 acetate,Ⅳ )、2 4 乙酰 2 5 脱水泽泻醇A (2 5 anhydroalisolA 2 4 ac etate ,Ⅴ )为新化合物 ,新泽泻醇 (neoalisol,Ⅵ )为新天然产物 ,其它已知成分是泽泻醇A(alisolA ,Ⅰ )、2 4 乙酰泽泻醇A(alisolA 2 4 acetate ,Ⅱ )、2 5 脱水泽泻醇A(2 5 anhydroalisolA ,Ⅲ )。     

泽泻梗的营养成分及对α-葡萄糖苷酶活性的影响

采用国标方法测定泽泻梗的营养成分,用化学比分法和氨基酸比值系数法对其蛋白质的营养价值进行评价。此外,还对泽泻梗粗提物抑制α-葡萄糖苷酶的活性进行了测定。结果表明:泽泻梗(每100 g干样)含粗蛋白26.10 g、粗脂肪2.20 g、总膳食纤维27.56 g、灰分8.70 g、多糖4.22 g、还原糖4.87 g、维生素C 406.30 mg、胡萝卜素380.00μg。泽泻梗蛋白质组成中必需氨基酸/总氨基酸(EAA/TAA)为39.54%、必需氨基酸/非必需氨基酸(EAA/NEAA)为60.46%,鲜味氨基酸占总氨基酸含量的40%以上;其第一限制性氨基酸为含硫氨基酸(蛋氨酸和胱氨酸)。浓度为500μg/m L的泽泻梗水提醇沉物、泽泻梗醇提物的α-葡萄糖苷酶抑制率分别为43.75%、39.90%。     

泽泻化学成分的研究

从泽泻（Alisma orientalis(Sam)Juzep）块茎中分离出12个化合物,经理化性质和波谱分析,分别鉴定为：β-谷甾醇3-O-硬脂酸酯（β-sistosterol-3-O-stearate,1）,正二十三烷（tricosane,2）,β-俗甾醇（β-sitosterol,5）,硬脂酸（stearic acid,6）1-硬脂酸甘油酯（glyeryl 1-stearate,7）,胡萝卜甙6′-O-硬脂酸酯（daucosterol-6′-O-stearate,8）,泽泻醇B单醋酸酯（alisol B monoacetate,9）,大黄素（emodin,10）,泽泻醇C单醋酸酯（alisol C monoacetate,11）,环氧泽泻烯（alismoxide,12）.化合物1,2,5,6,7和10为首次由该植物中获得,化合物12首次以结晶形式获得,化合物3和4的鉴定仍在进行。     

降脂中药复方的转运性相互作用——体外MDR1转运研究

目的:药物相互作用是影响药物安全和药效的重大因素之一。本文旨在通过体外MDR1研究方法——ATP酶法,评价降脂中药复方(Fang-2)及其单方6个饮片水提物与P-gp的相互作用,为临床中西药转运性相互作用提供参考。方法:应用标准化制备技术,制备降脂中药复方及其6个饮片水提物。利用基于MDR1膜的ATP酶法,计算MDR1细胞膜的ATP酶活性,考察药物与P-gp的相互作用。结果:1 mg·mL-1、10 mg·mL-1两个浓度中药复方的ATP酶活性分别为27.2、40.0 nmol Pi·min-1·mg-1protein,呈浓度依赖性。6个单方中,泽泻、厚朴、夏枯草与P-gp作用显著,其强弱顺序为:泽泻夏枯草厚朴(50.642.640.0 nmol Pi·min-1·mg-1protein)。泽泻单体23-乙酰泽泻醇B、24-乙酰泽泻醇A均与P-gp有较强的相互作用,ATP酶动力学研究显示其Km值和Vmax值分别为0.79±0.28μM,2.01±0.67μM和50.57±3.72 nmol Pi·min-1·mg-1protein,56.28±29.6 nmol Pi·min-1·mg-1protein。结论:Fang-2与MDR1存在相互作用,其中泽泻为主要被MDR1转运的饮片,泽泻的有效组分23-乙酰泽泻醇B和24-乙酰泽泻醇A均是MDR1底物。表明该降脂中药与临床上其他降脂药物的联用时应充分考虑MDR1介导的转运行相互作用,为临床用降脂药物提供参考和依据。     

福建泽泻元素分析及其属性判别研究

利用电感耦合等离子体质谱(ICP-MS),对福建建瓯产大叶、小叶泽泻中17种元素的含量进行了测定,在此基础上,运用SAS软件的DISCRIM过程对两类泽泻样品进行了判别分析,取得了良好的分类判别结果,利用上述方法得到的泽泻元素含量分布图谱有可能为中药材指纹图谱的建立及其规范化种植提供新的途径。     

泽泻化学成分的研究

采用硅胶柱层析的方法,从四川产泽泻中分离得到三个倍半萜类成分,经理化鉴别及波谱测定,鉴定为泽泻萜醇E（orientaloa E Ⅰ）,alismoxide(Ⅲ),alismol(Ⅳ),其中化合物Ⅰ为新化合物。     

多苞裂萼苔化学成分的研究

目的研究裂萼苔属植物多苞裂萼苔Chiloscyphus polyonthus(L.)Cord的化学成分.方法用硅胶、Sephadex LH-20柱层析分离原植物乙醇提取物,根据所得化合物的理化性质、波谱数据确定结构.结果分离得到两个倍半萜类化合物,分别鉴定为(-)-桉烷-3-烯-6α-乙酰氧-7α-醇(Ⅰ)、(+)-桉烷-3-烯-7a-醇(Ⅱ);此外,尚得到β-谷甾醇(Ⅲ)和胡萝卜苷(Ⅳ).结论化合物Ⅰ、Ⅱ、Ⅲ、Ⅳ均为首次从该植物中分离得到.     

大孔吸附树脂提取7-木糖-10-去乙酰紫杉醇酶解产物10-去乙酰紫杉醇

本研究利用大孔树脂富集7-木糖10-去乙酰紫杉醇的酶解产物10-去乙酰紫杉醇.首先以10-去乙酰紫杉醇(10-DAT)绝对含量为指标,通过HPLC测定比较HP20、XAD4、XAD16、XAD1600四种大孔树脂对10-去乙酰紫杉醇的吸附与解吸性能力,筛选出最佳树脂XAD1600进行实验.最佳的吸附解吸条件为:树脂柱高径比10:1,吸附流速20 mL/min,吸附量23.85 mg/mL,以6倍柱床体积的90%乙醇为洗脱液,洗脱流速20 mL/min.经XAD1600型树脂富集后10-去乙酰紫杉醇回收率达96.5%,含量20.5%.且树脂柱重复使用3次后,其吸附能力仅降低5%.     

Triterpenes from Alisma orientalis act as androgen receptor agonists,progesterone receptor antagonists,and glucocorticoid receptor antagonists

Alisma orientalis, a well-known traditional medicine, exerts numerous pharmacological effects including anti-diabetes, anti-hepatitis, and anti-diuretics but its bioactivity is not fully clear. Androgen receptor (AR), progesterone receptor (PR), and glucocorticoid receptor (GR) are three members of nuclear receptor superfamily that has been widely targeted for developing treatments for essential diseases including prostate cancer and breast cancer. In this study, two triterpenes, alisol M 23-acetate and alisol A 23-acetate from Alisma orientalis were determined whether they may act as androgen receptor (AR), progesterone receptor (PR), or glucocorticoid receptor (GR) modulators. Indeed, in the transient transfection reporter assays, alisol M 23-acetate and alisol A 23-acetate transactivated AR in dose-dependent manner, while they transrepressed the transactivation effects exerted by agonist-activated PR and GR. Through molecular modeling docking studies, they were shown to respectively interact with AR, PR, or GR ligand binding pocket fairly well. All these results indicate that alisol M 23-acetate and alisol A 23-acetate from Alisma orientalis might possess therapeutic effects through their modulation of AR, PR, and GR pathways.     

The binding mechanisms of plasma protein to active compounds in Alismaorientale rhizomes (Alismatis Rhizoma)

Ultrafiltration and HPLC were employed to assess binding rates between rat plasma protein and two active compounds with lipid-regulating properties (alisol B 23-acetate and alisol A 24-acetate) from Alismaorientale rhizomes (Alismatis Rhizoma), a traditional Chinese medicine. SDS–PAGE was used for the evaluation of the binding between the alisol acetates and Hb in plasma. The fluorescence spectroscopy and circular dichroism spectroscopy were also combined with molecular modeling to explore binding mechanisms between Hb and the alisol acetates under imitative physiological condition. The ultrafiltration results show that alisol B 23-acetate bound more strongly than alisol A 24-acetate to plasma protein. SDS–PAGE results may suggest that alisols bind to Hb in plasma. The spectroscopy results are consisting with the molecular modeling results, and they indicate that the differences in plasma protein binding strength between the two compounds may be related to their side chains. A folded side chain/parent ring bound more strongly to Hb than an open side chain/parent ring.     

Alisol A attenuates high‐fat‐diet‐induced obesity and metabolic disorders via the AMPK/ACC/SREBP‐1c pathway

Obesity and its associated metabolic disorders such as diabetes, hepatic steatosis and chronic heart diseases are affecting billions of individuals. However there is no satisfactory drug to treat such diseases. In this study, we found that alisol A, a major active triterpene isolated from the Chinese traditional medicine Rhizoma Alismatis, could significantly attenuate high‐fat‐diet‐induced obesity. Our biochemical detection demonstrated that alisol A remarkably decreased lipid levels, alleviated glucose metabolism disorders and insulin resistance in high‐fat‐diet‐induced obese mice. We also found that alisol A reduced hepatic steatosis and improved liver function in the obese mice model.In addition, protein expression investigation revealed that alisol A had an active effect on AMPK/ACC/SREBP‐1c pathway. As suggested by the molecular docking study, such bioactivity of alisol A may result from its selective binding to the catalytic region of AMPK.Therefore, we believe that Alisol A could serve as a promising agent for treatment of obesity and its related metabolic diseases.     

Studies on the lipid-regulating mechanism of alisol-based compounds on lipoprotein lipase

Studies on the lipid-regulating effects of alisol compounds are reported that include alisol B, alisol A 24-acetate (24A), alisol A and an alisol B - 24A - alisol A mixture (content ratio = 1:1:1). The effects on the activity of lipoprotein lipase (LPL), a key lipid-modulating enzyme, were studied to investigate the molecular mechanism of lipid-regulating activity of alisols. The effects of alisols on regulating blood lipids and the activities of LPL were determined using a reagent kit method. The structure of LPL was obtained by homology modeling and the interactive mechanism of alisol monomers and the mixture with LPL was investigated by molecular simulation. The alisol monomer and mixture were shown to regulate blood lipids, suggesting that alisols may decrease the level of triglyceride (TG) by improving the activity of LPL. The order of intensity was: mixture > alisol A > alisol B > 24A, indicating that alisols of alismatis rhizoma feature a synergistic effect on LPL. The N- and C-terminus of LPL both represented the catalytic active domains of this lipid-regulating effect. Cys306, Gln129 and Ser166 were the key amino acid residues resulting in the lipid-regulating effect of the alisol monomer while Ser166 and Arg18 were found to be responsible for the lipid-regulating effect of the mixture. The C-terminus of LPL was indirectly involved in the enzymatic process. A folded side chain of alisols or the parent ring was found to bind somewhat weaker to LPL than an open side chain or parent ring. The hydroxyl groups on the C14-, C22-, C28-, C30- and C31-terminus in the side chain, the ring ether structure in C23-position, and the acetyl group in C29-position represented the key sites for the lipid-regulating action of alisols. Meanwhile, the C30-site hydroxyl group played an important role in the synergistic effect of the alisol mixture.     

The antitumor molecular mechanism of Alisma orientalis with c-myc DNA: multi-spectroscopic analysis and molecular simulation

Abstract

We prepared extracts of Alisma orientalis from Sichuan and Fujian Province, China. Based on the ratio of alisol B 23-acetate (23B) to alisol A 24-acetate (24A) in two Alisma orientalis extracts, we prepared two mixtures of 24A and 23B (24A:23B?=?1:3 or 1:10). The antitumor molecular mechanism of the monomers 24A and 23B, the two mixtures and the effective components of Alisma orientalis from different habitats were studied. The MTT assay suggested that the difference in the antitumor activity of Alisma orientalis from different habitats was correlated to the ratio of 24A to 23B. The multi-spectroscopic analysis suggested that the effective components, the monomers and mixtures interacted with c-myc DNA in a partial intercalation manner. The binding strength of the alisol acetates to c-myc DNA was consistent with the anticancer activity, indicating that c-myc DNA was the anticancer target. The molecular simulation indicated that the mixtures were all directly bound to different base pairs of c-myc DNA for a superimposed effect, which led to the binding strength of the mixtures to c-myc DNA was stronger than that of the monomers. The molecules in the 1:3 mixture were all bound to different base pairs of c-myc DNA. However, for the 1:10 mixture, seven molecules of 23B bound to the side chain of 24A, resulting in the mixture with a long chain structure which increased the steric hindrance of 24A. As a result, affinity between 24A and c-myc DNA in the 1:10 mixture was weaker than that in the 1:3 mixture.

The antitumor molecular mechanism of the alisol monomers 24A and 23B, the mixtures with different proportions and the effective components of Alisma orientalis from different habitats were studied. The order of the antitumor activity was as follows: Sichuan?>?Fujian, 24A-23B (1:3) > 24A-23B (1:10) > 23B?>?24A. The antitumor activity of Alisma orientalis from different habitats was consistent with the mixtures which were designed according to the contents of the active ingredients of the medicinal materials, indicating that the antitumor activity of Alisma orientalis from Sichuan is better than that from Fujian which is related to the contents of 24A and 23B and the proportion of 1:3 is better than 1:10. The binding strength of the mixtures to c-myc DNA was consistent with the anticancer activity. The mixtures were all directly bound to different base pairs of c-myc DNA for a superimposed effect, which led to the strength of the interaction of the mixtures to c-myc DNA was stronger than that of the monomers. For the 24A-23B (1:3) mixture, the four small molecules bound to c-myc DNA directly and interacted with different base pairs of c-myc DNA. While for the 24A-23B (1:10) mixture, 24A and three 23B molecules interacted with c-myc DNA, the remaining seven 23B molecules bound to the side chain of 24A, which increased the steric hindrance. The binding of the mixture to c-myc DNA was decreased.

Communicated by Ramaswamy H. Sarma     

Triterpenes from Alisma orientalis act as farnesoid X receptor agonists

Alisma orientalis is a well-known traditional medicine exerting pharmacological effects including antidiabetes, antihepatitis, and antidiuretics, but the respective molecular mechanism is not completely clear. Farnesoid X receptor (FXR) is a member of nuclear receptor superfamily and viewed as one of the essential target proteins to develop antidiabetic treatments. In this study, the triterpenes, alisol M 23-acetate and alisol A 23-acetate, were isolated from A. orientalis and further evaluated for their activity against FXR. In the mammalian one-hybrid and transient transfection reporter assays, both triterpenes transactivated FXR to modulate promoter action including GAL4, SHP, CYP7A1, and PLTP promoters in dose-dependent manner, while they exhibited similar agonistic activity as chenodeoxycholic acid (CDCA), an endogenous FXR agonist. These results highly indicated that alisol M 23-acetate and alisol A 23-acetate acted as FXR agonists so A. orientalis might exert therapeutic effect including antihyperglycemic effect through FXR pathway.     

Effects of sesquiterpenes and triterpenes from the rhizome of Alisma orientale on nitric oxide production in lipopolysaccharide-activated macrophages: absolute stereostructures of alismaketones-B 23-acetate and -C 23-acetate

The methanolic extract from a Chinese herbal medicine, the rhizome of Alisma orientale, was found to exhibit inhibitory activity of nitric oxide (NO) production in lipopolysaccharide (LPS)activated macrophages. Novel triterpenes, alismaketones-B 23-acetate and -C 23-acetate, were isolated from the active extract together with eight sesquiterpenes and eighteen protostane-type triterpenes. The absolute stereostructures of new triterpenes were characterized on the basis of chemical and physicochemical evidence, which included the chemical correlations with known triterpenes. The guaiane-type sesquiterpenes (alismol, orientalols A and C) and protostane- and seco-protostane-types triterpenes (alisols C monoacetate, E-23-acetate, F, H, I, L-23-acetate, and M-23-acetate, alismaketones-B 23-acetate and -C 23-acetate, alismalactone 23-acetate, and 3-methylalismalactone 23-acetate) inhibited LPS-induced NO production (IC50 = 8.4-68 microM). Other triterpenes (alisols A, A monoacetate, B, B monoacetate, E, G, K-23-acetate, and N-23-acetate and 11-deoxyalisol B) also showed the potent inhibitory activity, but they showed cytotoxic effects more than 30 microM (MTT assay). In addition, alismol and alisol F were found to suppress iNOS induction.     

Biotransformation of alisol G by Penicillium janthinellum and the hCE2 inhibitory effects of its metabolites

Alisol G, also named 25-anhydroalisol A, is a major triterpene obtained from dried rhizomes of Alisma orientalis. This paper investigated the transformation of alisol G by fungi and evaluated the hCE2 inhibitory effects of the transformed products. By screening whole cells of 10 strains of filamentous fungi, Penicillium janthinellum AS 3.510 exhibited a special capability to transform alisol G. Four metabolites were obtained, which were determined to be new compounds on the basis of spectroscopic data, including UV, 1D- and 2D-NMR, and HRESIMS. In addition, in an in vitro bioassay, metabolites 1–4 showed significant hCE2 inhibitory activities with IC₅₀ values of 6.81, 16.66, 3.38, and 6.33 μM, respectively.